Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 8 M9 M11 M8 M8 M 36 M Research & development ————— — Operating income 289 M211 M238 M252 M202 M 903 M Non-Operating Income, Total -373 M-444 M-416 M-408 M-337 M -1.6 B Interest expense, net of interest capitalized 186 M188 M209 M210 M213 M 820 M Non-Operating Income, excl. Interest Expenses -559 M-632 M-625 M-618 M-550 M -2.42 B Unusual income/expense ————— — Pretax income -92 M-241 M-187 M-165 M401 M -192 M Equity in earnings ————— — Taxes ————— — Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations 241 M361 M404 M293 M92 M 1.15 B Discontinued operations ————— — Net income 241 M361 M404 M293 M92 M 1.15 B Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 241 M361 M404 M293 M92 M 1.15 B Basic earnings per share (Basic EPS) 0.360.520.570.410.13 1.63 Diluted earnings per share (Diluted EPS) 0.360.520.570.410.13 1.63 Average basic shares outstanding 676 M695 M709 M699 M718 M — Diluted shares outstanding 676 M695 M709 M699 M718 M — EBITDA 293 M215 M243 M256 M208 M 922 M EBIT 289 M211 M238 M252 M202 M 903 M Cost of revenue ————— — Other cost of goods sold ————— — Depreciation & amortization (cash flow) 4 M4 M5 M4 M6 M 19 M